[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002278:Carcinoma in Situ / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D013713:Teniposide / Q000008:administration & dosage; D013852:Thiotepa / Q000008:administration & dosage; D001743:Urinary Bladder / Q000187:drug effects; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin; D003520:Cyclophosphamide; D013852:Thiotepa; D013713:Teniposide; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate
Möglichkeiten und Wertigkeit der intrakavitären und systemischen Chemotherapie des Harnblasenkarzinoms.